AstraZeneca gets regulatory approvals for two cancer drugs in Japan

This article was originally published here

AstraZeneca has secured regulatory approvals for two major cancer drugs, Imfinzi and Lynparza, in Japan.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply